Skip to main content
Premium Trial:

Request an Annual Quote

BD Acquires GeneOhm Sciences for $230M in Bid to Bolster Infectious-Disease Play

NEW YORK, Jan. 10 (GenomeWeb News) - Becton Dickinson has acquired GeneOhm Sciences for $230 million plus up to $25 million in additional incentives, BD said today.


GeneOhm is a privately held company headquartered in San Diego that develops molecular diagnostics designed to detect bacteria known to cause healthcare-associated infections. BD said that GeneOhm had 2005 revenues of approximately $5 million, and provides BD with expanded entry into the emerging HAI market.


Specifically, GeneOhm markets FDA-cleared IDI-MRSA and IDI-Strep B diagnostic tests. MRSA, also known as methicillin-resistant Staphylococcus aureus, is responsible for HAIs, and Group B Strep poses a risk to pregnant women and their children during the latter stages of pregnancy.


The acquisition is subject to regulatory approvals and is expected to close by the end of March 2006. BD also said that the GeneOhm transaction is slightly dilutive. However, it reaffirms its previous guidance that reported diluted earnings per share from continuing operations for fiscal year 2006 are expected to be in the range of $3.15 to $3.19. BD said it will provide further details around this guidance during its first quarter earnings call on January 26.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.